In one paragraphArticle in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Anastasia A VorobevaG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.ORCID 0009-0007-7680-766X Aleksei M VorobevG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.ORCID 0000-0003-4724-2464 Peter V EvseevLaboratory of Molecular Microbiology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.ORCID 0000-0002-1646-9802 Emil R MekhtievG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Andrei V ChaplinLaboratory of Molecular Microbiology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.ORCID 0000-0003-1377-7153 Maria A PasivkinaG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Ekaterina S ZubkovaG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Svetlana S BochkarevaG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Mikhail A YaitskyLaboratory of Molecular Microbiology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.ORCID 0009-0000-2911-4907 Nikolai A NikitinDepartment of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0001-9626-2336 Natalia B DeminaA.P. Nelyubin Institute of Pharmacy, Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
Victoria A KorolA.P. Nelyubin Institute of Pharmacy, Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.ORCID 0000-0002-8587-7965 Andrei V AleshkinLimited Liability Company Orphan-BIO, 354340 Sirius, Russia.
Anatolij N BlintsovLimited Liability Company Natura Siberica, 119571 Moscow, Russia.
Maria N AnurovaG.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Bacteriophages are promising antibacterial agents for managing acne vulgaris caused by
Indexed as
BacteriophagesGenome, ViralPropionibacterium acnesDNA, ViralGenomicsHumansOpen Reading FramesPhylogenySequence Analysis, DNADNA, ViralacnebacteriophagesCutibacterium acnesgenomic characterizationPahexavirusesphage therapyphenotypic characterization
Identifiers
PMID41754558
PMCPMC12945031
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390